Comparison of serum free light chain and urine electrophoresis for the detection of the light chain component of monoclonal immunoglobulins in light chain and intact immunoglobulin multiple myeloma | Haematologica
Freelite® & Hevylite®
Comparison of Freelite™ and N Latex serum free light chain assays in subjects with end stage kidney disease on haemodialysis
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia
International Clinical Product Listing
Freelite® & Hevylite®
Comparison of Freelite™ and N Latex serum free light chain assays in subjects with end stage kidney disease on haemodialysis
Comparison of serum free light chain and urine electrophoresis for the detection of the light chain component of monoclonal immunoglobulins in light chain and intact immunoglobulin multiple myeloma | Haematologica
Freelite® Human Kappa Free kit For use on the Roche Cobas Integra® For in vitro diagnostic use Product Code: LK016.RI
Serum free light chain ratio as a biomarker for high-risk smoldering multiple myeloma | Leukemia
Response to Jacobs: N Latex FLC serum free light-chain assays in patients with renal impairment
Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance - ScienceDirect
PDF) Comparison of Freelite™ and N Latex serum free light chain assays in subjects with end stage kidney diesease on haemolysis
Comparison of two serum free light chain assays for the diagnosis of primary plasma cell malignant proliferative disease - Yang - 2019 - Health Science Reports - Wiley Online Library
Serum free light chain assays (Freelite®) are recommended by the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines
Monitoring serum free light chains in patients with multiple myeloma who achieved negative immunofixation after allogeneic stem cell transplantation | Haematologica
Comparison of serum free light chain and urine electrophoresis for the detection of the light chain component of monoclonal immunoglobulins in light chain and intact immunoglobulin multiple myeloma | Haematologica
Untitled
Binding Site | What is Freelite
Comparison of two serum free light chain assays for the diagnosis of primary plasma cell malignant proliferative disease - Yang - 2019 - Health Science Reports - Wiley Online Library
Verification of Newly FDA-Approved Kappa and Lambda Free Light Chain Assays on a Previously Untested Platform
Cancers | Free Full-Text | Lenalidomide Maintenance and Measurable Residual Disease in a Real-World Multiple Myeloma Transplanted Population Receiving Different Treatment Strategies Guided by Access to Novel Drugs in Brazil